Scanning the horizon for high value-add manufacturing science: Accelerating manufacturing readiness for the next generation of disruptive, high-value curative cell therapeutics. (2018)
Attributed to:
The Pluripotent Stem Cell Platform (PSCP)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jcyt.2018.01.007
PubMed Identifier: 29673565
Publication URI: http://europepmc.org/abstract/MED/29673565
Type: Journal Article/Review
Volume: 20
Parent Publication: Cytotherapy
Issue: 5
ISSN: 1465-3249